Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DePTH: Low-dose calcitriol vs usual care in hemodialysis
NCT06288451Phase 2Active, not recruiting
- Sponsor
- University of Washington
- Start
- Mar 2024
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in secondary hyperparathyroidism (SHPT), sponsored by University of Washington. Started Mar 2024; status: active, not recruiting.
02
Drugs
calcitriol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT06288451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06288451.